Record Q2 revenue and gross margin driven by strong healthcare demand and new market launches. Largest-ever order secured in Australia/New Zealand, with NHS listing in the UK and continued expansion of Smell Training.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.